Preserve biomedical research funding to save lives, drive innovation

The President's proposed budget would severely undermine biomedical research in the United States by cutting nearly 40% from the National Institutes of Health's budget. This $18 billion reduction would decimate funding for lifesaving work across disciplines like cancer, infectious diseases, Alzheimer's and more. Only three institutes would remain intact, with devastating cuts even to those prioritized areas. The NIH drives innovation that improves and saves lives. Its research underpins development of new treatments, fuels private sector investment, and keeps America at the forefront of global scientific leadership. Deep cuts would cripple progress against diseases impacting millions, trigger brain drain as top researchers seek opportunities elsewhere, and inflict immense economic harm by stifling a major innovation engine. Stable and robust funding for the NIH is a necessity, not a luxury. Pursuing these draconian cuts would represent an extremely short-sighted decision trading human lives and quality of life for modest budgetary savings. Biomedical research demands consistent federal investment as it lays the groundwork for a healthier, more prosperous society. A strong NIH reinforces America's global competitiveness and underscores our national commitment to accelerating medical breakthroughs for all.